We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · June 20, 2022

Presence and Implications of Anti-ACE2 IgM Antibodies in Anti-MDA5 Dermatomyositis

ACR Open Rheumatology


Additional Info

ACR Open Rheumatology
Presence and Implications of Anti-Angiotensin Converting Enzyme-2 Immunoglobulin M Antibodies in Anti-Melanoma-Differentiation-Associated 5 Dermatomyositis
ACR Open Rheumatol 2022 May 01;4(5)457-463, CA Mecoli, A Yoshida, JJ Paik, CT Lin, S Danoff, H Hanaoka, A Rosen, L Christopher-Stine, M Kuwana, L Casciola-Rosen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading